Recombinant human growth hormone promotes human lymphocyte engraftment in immunodeficient mice and results in an increased incidence of human Epstein Barr virus-induced B-cell lymphoma
- 31 December 1992
- journal article
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 6 (4) , 355-364
- https://doi.org/10.1016/0889-1591(92)90034-l
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Growth hormone exerts hematopoietic growth-promoting effects in vivo and partially counteracts the myelosuppressive effects of azidothymidineBlood, 1992
- Immunologic and hematologic effects of neuroendocrine hormones. Studies on DW/J dwarf mice.The Journal of Immunology, 1992
- Human‐mouse lymphoid chimeras: host‐vs.‐graft and graft‐vs.‐host reactionsEuropean Journal of Immunology, 1992
- The Persistence of Human Peripheral Lymphocytes, Tumor Infiltrating Lymphocytes, and Colon Adenocarcinomas in Immunodeficient MiceJournal of Immunotherapy, 1992
- Immunodeficient mice xenografted with human lymphoid cells: New models forin vivo studies of human immunobiology and infectious diseasesJournal of Clinical Immunology, 1990
- Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cellsJournal of Virology, 1990
- Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice.Journal of Clinical Investigation, 1990
- Growth hormone, lymphocytes and macrophagesBiochemical Pharmacology, 1989
- Transfer of a functional human immune system to mice with severe combined immunodeficiencyNature, 1988
- Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiencyCell, 1986